Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022 - PubMed
3 hours ago
- #Evidence-Based Medicine
- #Vascular Anomalies
- #Clinical Practice Guidelines
- The guidelines aim to provide evidence-based treatment recommendations for vascular anomalies, including vascular tumors, vascular malformations, lymphatic malformations, and lymphangiomatosis.
- A systematic review of literature from 1980 to December 2020 was conducted using PubMed and Japana Centra Revuo Medicina (JCRM) to address 38 clinical questions (CQs).
- The recommendations cover various treatments such as resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and conservative management, considering lesion location, symptoms, timing, and diagnosis.
- The guidelines are based on the Medical Information Network Distribution Service (Minds) methodology for evaluating evidence and recommendation strengths.
- This update represents the 2022 version of the Japanese Clinical Practice Guidelines, building on previous editions from 2013 and 2017.